Skip to main content
Clinical Trials/ACTRN12622000418774
ACTRN12622000418774
Active, not recruiting
未知

Discovery of New Biomarkers of Cardiac Susceptibility in Fabry Disease that may be used to Improve the Precision of Targeted Fabry-Specific Therapy Delivery

The University of Sydney0 sites50 target enrollmentMarch 11, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Fabry Disease
Sponsor
The University of Sydney
Enrollment
50
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • a) Age 18 years or older
  • b) Males and females
  • c) Genetically confirmed Fabry disease
  • d) Indication for a CMR, or appropriate historical CMR study within 36\-months of enrolment; and
  • e) Willing and able to provide informed consent by self

Exclusion Criteria

  • a) Patients highly dependent on medical care and unable to provide informed consent;
  • b) Unwilling or unable to participate in 1\-year follow\-up
  • c) People with cognitive impairment, intellectual disability, or mental illness that prevent them from providing informed consent for themselves.

Outcomes

Primary Outcomes

Not specified

Similar Trials